openPR Logo
Press release

Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024

01-10-2024 08:43 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Birnbach Communications Inc.

/ PR Agency: Birnbach Communications
Birnbach Communications, Inc. (www.birnbachcom.com), a PR and social media agency focusing on thought leadership, today issued its 22nd annual list of top media and marketing trends for the upcoming year.

"We expect generative AI, including ChatGPT, to continue to be the big story, the focus will be on the impact it will have on companies and consumers alike. Capabilities are growing at phenomenal rates, and from a content-generation perspective, organizations and educators need to understand what's possible and how to use these new tools and processes," said Norman Birnbach, president, Birnbach Communications. "By identifying these trends, we can help uncover media and business opportunities for clients across industries, such as tech, biotech and life science, AI and robotics, STEM and education."

Here are the agency's predictions of the top five trends that will drive media coverage and social media discussions in 2024:

1. Growing popularity of generative AI may upend copyrighting, pricing and public trust. Beyond changing the way we work, AI also will change how we produce and value content, whether text, audio, or visual. In addition to lots of articles reporting on fast-improving AI capabilities and forecasts of companies that will succeed or fail, we will see many think pieces about generative AI's potential impact on humanity, as well as problems such as copyrighting issues, hallucinations (false information, citations and links in AI-produced text as well as similar problems with AI-produced images). We will hear a lot about value-based marketing, representing a shift in how companies value and price work created by AI, including downward pressure on the cost to produce content despite the need for skilled practitioners to produce compelling content of any kind. One major magazine already got called out for publishing AI-produced articles under fake bylines, and we think that should serve as a cautionary tale for publications. (Please note: this entire release/article was written and edited by humans. For more about AI hallucinations, check out this New York Times article.)
2. Drug availability and cost are expected to drive attention at the highest levels. We anticipate the media to report on the impact of capping insulin prices, tied to Pres. Biden's State of the Union address on March 7 because he announced that plan at last year's SOTU and because it's been a year since Eli Lilly reduced its insulin to $35/month. We expect the media to pay more attention to drug shortages affecting 309 medications for ADHD, cancer, diabetes and other conditions, some of it due to supply chain and market issues like slim profit margins on older drugs. Meanwhile, prices increased 15.2% from Jan. 2022 to Jan. 2023 on more than 4,200 drugs, according to the US Dept. of HHS. We expect that those two trends will generate media attention.
3. With FDA approval of gene therapies for sickle cell disease, expect more good news for CRISPR, along with media concern about access to healthcare. A gene-editing tool that's been around for a decade and whose developers received the Nobel Prize for it in 2020, CRISPR has been forecast to be the future of precise medical therapy, and could benefit from additional FDA approvals for other CRISPR therapies in addition to sickle cell disease. Sickle cell patients are likely to face problems with access, cost, and possible "insurance obstacles" (as the New York Times described it). We do expect additional CRISPR therapies to be approved this year and that the access and cost issues will be resolved but that won't be this year.
4. All eyes will be on the content moderation and rising influence of social media in this election year. Misinformation and disinformation will rise across social media platforms this year especially - but not only - because of the 2024 elections. We expect coverage about content curation, including algorithms, and whether social media is pushing Big Tech's agenda. We also expect think pieces about free speech and social media as virtual town squares, particularly on X, the social media platform you love to hate because there's so much hate and trolling. We also expect to see more coverage of the declining value of X under Musk's ownership. TikTok will also continue to receive attention because of its rising influence, its connection to China, and calls to limit TikTok in the U.S.
5. EVs may not be ready for prime time due to battery storage and electrification issues, but climate change will keep the focus on this nascent industry. We expect carbon capture as a way to reduce carbon emissions, along with wind power and solar to move forward this year but the media will be most interested in electric vehicles (EVs). The major shortage of charging stations will hamper EV growth until most drivers feel they can charge their cars wherever they are, which is connected to the electrification problem. Despite the stress of the U.S. electrical grid in states like Texas, we need to expand and upgrade it to support new charging stations and increasing demand for electrical devices and appliances. We also expect that battery storage capacity will be increasingly important, with emerging technologies like iron-air or zinc-based batteries and hydrogen-based storage, or new approaches combining hybrid battery and hydrogen fuel cell systems to provide longer-term storage.

These other trends will be rolled out on the agency's blog, PRBackTalk: birnbachcom.com/PRBackTalk.

Norman Birnbach
Birnbach Communications
20 Devereux St., Ste 3A
Marblehead, MA 01945

About Birnbach Communications
Boston-based Birnbach Communications, an independent PR and social media agency, partners with its clients to strategically navigate the complex and ever-changing communication landscape. The agency enables its client base of growing technology-driven and life science companies to achieve leadership in a crowded business market by helping them launch products and services; establish new product categories; and drive market demand through media and influencer relations, social media, and thought leadership campaigns. Founded in 2001, Birnbach Communications brings flexible senior-level intelligence and a proven, pragmatic approach to solving clients' business challenges. Connect with Birnbach: Web: www.birnbachcom.com, Twitter: twitter.com/#!/birnbachcomm; Blog: http://birnbachcom.com/PRBackTalk/; Facebook: www.facebook.com/BirnbachCommunications | Linkedin: www.linkedin.com/company/birnbach-communications.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024 here

News-ID: 3347278 • Views:

More Releases for CRISPR

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields. CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632 This latest report researches the industry structure, sales,
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries. It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401 The report provides a comprehensive analysis of company profiles listed below: -
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about